These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2864150)

  • 21. Neural influences and sudden cardiac death.
    Verrier RL; Lown B
    Adv Cardiol; 1978; 25():155-68. PubMed ID: 30259
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of arrhythmias in ischemic heart disease. The role of beta blockers.
    Morganroth J
    Postgrad Med; 1988 Feb; Spec No():113-9. PubMed ID: 2894654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload.
    Gilsbach R; Schneider J; Lother A; Schickinger S; Leemhuis J; Hein L
    Cardiovasc Res; 2010 Jun; 86(3):432-42. PubMed ID: 20083574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical pharmacology of beta adrenergic blocking agents].
    Toyama S; Suzuki K
    Nihon Rinsho; 1973 Sep; 31(9):2687-95. PubMed ID: 4148964
    [No Abstract]   [Full Text] [Related]  

  • 25. Pivotal role of the sympathetic nerves of the human heart in mental stress responses and triggered cardiovascular catastrophes.
    Esler M
    Auton Neurosci; 2022 Jan; 237():102925. PubMed ID: 34896690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sympathoadrenergic mechanisms in reduced hemodynamic stress responses after exercise.
    Brownley KA; Hinderliter AL; West SG; Girdler SS; Sherwood A; Light KC
    Med Sci Sports Exerc; 2003 Jun; 35(6):978-86. PubMed ID: 12783046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure.
    Newton GE; Parker JD
    Circulation; 1996 Aug; 94(3):353-8. PubMed ID: 8759076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heart effect of arterial hypertension. Heart hypertrophy as a risk factor. Study technics (electrocardiogram, echocardiography, exercise test and Holter].
    Aguilera Saldaña MA; García Moreno LM; Rodríguez Padial L; Navarro Lima A; Sánchez Domínguez J
    Rev Esp Cardiol; 1990; 43 Suppl 1():54-64. PubMed ID: 2139976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered sympathetic tone in hypertensives with angina and lowered threshold for pacing ischemia.
    Oishi S; Yurenev A; Parfyonova E; Lee DD; Dubov P; Nikulin I; Kosenko A; Konyaeva E; Balyakina E; Atakhanov S
    Am J Hypertens; 1992 Jun; 5(6 Pt 2):154S-163S. PubMed ID: 1632936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corcoran Lecture. Sympathetic hyperactivity and coronary risk in hypertension.
    Julius S
    Hypertension; 1993 Jun; 21(6 Pt 2):886-93. PubMed ID: 8505097
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiovascular regulation and lesions of the central nervous system.
    Talman WT
    Ann Neurol; 1985 Jul; 18(1):1-13. PubMed ID: 3898997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma catecholamine responses to dynamic exercise in patients with coronary artery disease--the relationship between sympathetic activity and systolic blood pressure and exercise-induced ventricular arrhythmias.
    Miyakoda H; Noguchi N; Matsumoto T; Kitamura H; Kinugawa T; Ogino K; Hoshio A; Kotake H; Mashiba H
    Jpn Circ J; 1992 Nov; 56(11):1115-23. PubMed ID: 1453536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sympathetic system and hypertension.
    Esler M
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):99S-105S. PubMed ID: 10921528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The sympathetic neurobiology of essential hypertension: disparate influences of obesity, stress, and noradrenaline transporter dysfunction?
    Esler M; Rumantir M; Kaye D; Lambert G
    Am J Hypertens; 2001 Jun; 14(6 Pt 2):139S-146S. PubMed ID: 11411749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1,4-Dihydropyridines versus beta-blockers for hypertension: are either safe for the heart?
    Leenen FH
    Cardiovasc Drugs Ther; 1996 Sep; 10(4):397-402. PubMed ID: 8924051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inter-relationships between hypertension, left ventricular hypertrophy and coronary heart disease.
    Devereux RB; Roman MJ
    J Hypertens Suppl; 1993 Jun; 11(4):S3-9. PubMed ID: 8377033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology.
    Goldstein DS
    Am J Cardiol; 1981 Dec; 48(6):1147-54. PubMed ID: 6171157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The sympathetic nervous system and sudden cardiac death].
    Schwartz PJ
    G Ital Cardiol; 1981; 11(9):1191-7. PubMed ID: 7035263
    [No Abstract]   [Full Text] [Related]  

  • 40. Stress and sudden death. The case of the long QT syndrome.
    Schwartz PJ; Zaza A; Locati E; Moss AJ
    Circulation; 1991 Apr; 83(4 Suppl):II71-80. PubMed ID: 2009631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.